Skip to main content
Erschienen in: Neuroradiology 7/2012

01.07.2012 | Functional Neuroradiology

In vivo evaluation of white matter pathology in patients of progressive supranuclear palsy using TBSS

verfasst von: Jitender Saini, Bhavani Shankara Bagepally, Mangalore Sandhya, Shaik Afsar Pasha, Ravi Yadav, Pramod Kumar Pal

Erschienen in: Neuroradiology | Ausgabe 7/2012

Einloggen, um Zugang zu erhalten

Abstract

Introduction

The purpose of this research is to study white matter (WM) changes in patients of progressive supranuclear palsy (PSP) using automated analysis of diffusion tensor imaging (DTI) indices.

Methods

This was a prospective study comprising of 24 patients of PSP and 26 matched healthy controls. Fractional anisotropy, mean diffusivity (MD), axial diffusivity, and radial diffusivity (RD) changes were studied in the WM of the PSP patients using an automated analysis technique, tract-based spatial statistics (TBSS). Two subtypes of PSP, i.e., classic Richardson’s syndrome (PSP-RS) and parkinsonian type (PSP-P), were also compared among themselves to identify relative severity of WM changes as well as identify spatial distribution of the differences. Clinicoradiological correlation was done to determine the strength of correlation between WM abnormalities identified using TBSS and clinical scores.

Results

There were areas of significant abnormality seen in the frontoparietal cerebral WM, thalamus, midbrain tectum, superior cerebellar peduncle, and cerebellar WM. The abnormalities were more spatially widespread on MD and RD maps. Compared to PSP-P, the patients of PSP-RS had more spatial abnormalities localized to the frontal WM. There was no correlation between the observed WM changes and clinical rating scales.

Conclusions

The TBSS analysis showed widespread WM abnormalities in PSP patients including areas which have been shown to be involved in previous pathological studies. PSP-RS showed more severe white matter abnormality compared to the PSP-P subtype.
Literatur
1.
Zurück zum Zitat Litvan I (2003) Update on epidemiological aspects of progressive supranuclear palsy. Mov Disord 18(Suppl 6):S43–S50PubMedCrossRef Litvan I (2003) Update on epidemiological aspects of progressive supranuclear palsy. Mov Disord 18(Suppl 6):S43–S50PubMedCrossRef
2.
Zurück zum Zitat Carrilho PE, Barbosa ER (2002) Progressive supranuclear palsy in a sample of Brazilian population: clinical features of 16 patients. Arq Neuropsiquiatr 60(4):917–922PubMedCrossRef Carrilho PE, Barbosa ER (2002) Progressive supranuclear palsy in a sample of Brazilian population: clinical features of 16 patients. Arq Neuropsiquiatr 60(4):917–922PubMedCrossRef
3.
Zurück zum Zitat Nath U, Ben-Shlomo Y, Thomson RG, Lees AJ, Burn DJU (2003) Clinical features and natural history of progressive supranuclear palsy: a clinical cohort study. Neurology 60(6):910–916PubMedCrossRef Nath U, Ben-Shlomo Y, Thomson RG, Lees AJ, Burn DJU (2003) Clinical features and natural history of progressive supranuclear palsy: a clinical cohort study. Neurology 60(6):910–916PubMedCrossRef
4.
Zurück zum Zitat Lubarsky M, Juncos JL (2008) Progressive supranuclear palsy: a current review. Neurologist 14:79–88PubMedCrossRef Lubarsky M, Juncos JL (2008) Progressive supranuclear palsy: a current review. Neurologist 14:79–88PubMedCrossRef
5.
Zurück zum Zitat Morris HR, Wood NW, Lees AJ (1999) Progressive supranuclear palsy (Steele–Richardson–Olszewski disease). Postgrad Med J 75:579–584PubMed Morris HR, Wood NW, Lees AJ (1999) Progressive supranuclear palsy (Steele–Richardson–Olszewski disease). Postgrad Med J 75:579–584PubMed
6.
Zurück zum Zitat Price S, Paviour D, Scahill R, Stevens J, Rossor M, Lees A, Fox N (2004) Voxel-based morphometry detects patterns of atrophy that help differentiate progressive supranuclear palsy and Parkinson’s disease. Neuroimage 23(2):663–669PubMedCrossRef Price S, Paviour D, Scahill R, Stevens J, Rossor M, Lees A, Fox N (2004) Voxel-based morphometry detects patterns of atrophy that help differentiate progressive supranuclear palsy and Parkinson’s disease. Neuroimage 23(2):663–669PubMedCrossRef
7.
Zurück zum Zitat Brenneis C, Seppi K, Schocke M, Benke T, Wenning GK, Poewe W (2004) Voxel based morphometry reveals a distinct pattern of frontal atrophy in progressive supranuclear palsy. J Neurol Neurosurg Psychiatry 75(2):246–249PubMed Brenneis C, Seppi K, Schocke M, Benke T, Wenning GK, Poewe W (2004) Voxel based morphometry reveals a distinct pattern of frontal atrophy in progressive supranuclear palsy. J Neurol Neurosurg Psychiatry 75(2):246–249PubMed
8.
Zurück zum Zitat Padovani A, Borroni B, Brambati SM, Agosti C, Broli M, Alonso R, Scifo P, Bellelli G, Alberici A, Gasparotti R, Perani D (2006) Diffusion tensor imaging and voxel based morphometry study in early progressive supranuclear palsy. J Neurol Neurosurg Psychiatry 77(4):457–463PubMedCrossRef Padovani A, Borroni B, Brambati SM, Agosti C, Broli M, Alonso R, Scifo P, Bellelli G, Alberici A, Gasparotti R, Perani D (2006) Diffusion tensor imaging and voxel based morphometry study in early progressive supranuclear palsy. J Neurol Neurosurg Psychiatry 77(4):457–463PubMedCrossRef
9.
Zurück zum Zitat Cordato NJ, Duggins AJ, Halliday GM, Morris JG, Pantelis C (2005) Clinical deficits correlate with regional cerebral atrophy in progressive supranuclear palsy. Brain 128:1259–1266PubMedCrossRef Cordato NJ, Duggins AJ, Halliday GM, Morris JG, Pantelis C (2005) Clinical deficits correlate with regional cerebral atrophy in progressive supranuclear palsy. Brain 128:1259–1266PubMedCrossRef
10.
Zurück zum Zitat Agosta F, Kostić VS, Galantucci S, Mesaros S, Svetel M, Pagani E, Stefanova E, Filippi M (2010) The in vivo distribution of brain tissue loss in Richardson's syndrome and PSP—parkinsonism: a VBM-DARTEL study. Eur J Neurosci 32(4):640–647PubMedCrossRef Agosta F, Kostić VS, Galantucci S, Mesaros S, Svetel M, Pagani E, Stefanova E, Filippi M (2010) The in vivo distribution of brain tissue loss in Richardson's syndrome and PSP—parkinsonism: a VBM-DARTEL study. Eur J Neurosci 32(4):640–647PubMedCrossRef
11.
Zurück zum Zitat Whitwell JL, Avula R, Master A, Vemuri P, Senjem ML, Jones DT, Jack CR Jr, Josephs KA (2011) Disrupted thalamocortical connectivity in PSP: a resting-state fMRI, DTI, and VBM study. Parkinsonism Relat Disord 17(8):599–605PubMedCrossRef Whitwell JL, Avula R, Master A, Vemuri P, Senjem ML, Jones DT, Jack CR Jr, Josephs KA (2011) Disrupted thalamocortical connectivity in PSP: a resting-state fMRI, DTI, and VBM study. Parkinsonism Relat Disord 17(8):599–605PubMedCrossRef
12.
Zurück zum Zitat Whitwell JL, Master AV, Avula R, Kantarci K, Eggers SD, Edmonson HA, Jack CR Jr, Josephs KA (2011) Clinical correlates of WM tract degeneration in progressive supranuclear palsy. Arch Neurol 68(6):753–760CrossRef Whitwell JL, Master AV, Avula R, Kantarci K, Eggers SD, Edmonson HA, Jack CR Jr, Josephs KA (2011) Clinical correlates of WM tract degeneration in progressive supranuclear palsy. Arch Neurol 68(6):753–760CrossRef
13.
Zurück zum Zitat Wang J, Wai Y, Lin WY, Ng S, Wang CH, Hsieh R, Hsieh C, Chen RS, Lu CS (2010) Microstructural changes in patients with progressive supranuclear palsy: a diffusion tensor imaging study. J Magn Reson Imaging 32(1):69–75PubMedCrossRef Wang J, Wai Y, Lin WY, Ng S, Wang CH, Hsieh R, Hsieh C, Chen RS, Lu CS (2010) Microstructural changes in patients with progressive supranuclear palsy: a diffusion tensor imaging study. J Magn Reson Imaging 32(1):69–75PubMedCrossRef
14.
Zurück zum Zitat Kvickström P, Eriksson B, van Westen D, Lätt J, Elfgren C, Nilsson C (2011) Selective frontal neurodegeneration of the inferior fronto-occipital fasciculus in progressive supranuclear palsy (PSP) demonstrated by diffusion tensor tractography. BMC Neurol 11:13PubMedCrossRef Kvickström P, Eriksson B, van Westen D, Lätt J, Elfgren C, Nilsson C (2011) Selective frontal neurodegeneration of the inferior fronto-occipital fasciculus in progressive supranuclear palsy (PSP) demonstrated by diffusion tensor tractography. BMC Neurol 11:13PubMedCrossRef
15.
Zurück zum Zitat Knake S, Belke M, Menzler K, Pilatus U, Eggert KM, Oertel WH, Stamelou M, Höglinger GU (2010) In vivo demonstration of microstructural brain pathology in progressive supranuclear palsy: a DTI study using TBSS. Mov Disord 25(9):1232–1238PubMedCrossRef Knake S, Belke M, Menzler K, Pilatus U, Eggert KM, Oertel WH, Stamelou M, Höglinger GU (2010) In vivo demonstration of microstructural brain pathology in progressive supranuclear palsy: a DTI study using TBSS. Mov Disord 25(9):1232–1238PubMedCrossRef
16.
Zurück zum Zitat Erbetta A, Mandelli ML, Savoiardo M, Grisoli M, Bizzi A, Soliveri P, Chiapparini L, Prioni S, Bruzzone MG, Girotti F (2009) Diffusion tensor imaging shows different topographic involvement of the thalamus in progressive supranuclear palsy and corticobasal degeneration. AJNR Am J Neuroradiol 30(8):1482–1487PubMedCrossRef Erbetta A, Mandelli ML, Savoiardo M, Grisoli M, Bizzi A, Soliveri P, Chiapparini L, Prioni S, Bruzzone MG, Girotti F (2009) Diffusion tensor imaging shows different topographic involvement of the thalamus in progressive supranuclear palsy and corticobasal degeneration. AJNR Am J Neuroradiol 30(8):1482–1487PubMedCrossRef
17.
Zurück zum Zitat Smith SM, Jenkinson M, Johansen-Berg H, Rueckert D, Nichols TE, Mackay CE, Watkins KE, Ciccarelli O, Cader MZ, Matthews PM, Behrens TE (2006) Tract-based spatial statistics: voxelwise analysis of multi-subject diffusion data. Neuroimage 31:1487–1505PubMedCrossRef Smith SM, Jenkinson M, Johansen-Berg H, Rueckert D, Nichols TE, Mackay CE, Watkins KE, Ciccarelli O, Cader MZ, Matthews PM, Behrens TE (2006) Tract-based spatial statistics: voxelwise analysis of multi-subject diffusion data. Neuroimage 31:1487–1505PubMedCrossRef
18.
Zurück zum Zitat Smith SM, Nichols TE (2009) Threshold-free cluster enhancement: addressing problems of smoothing, threshold dependence and localisation in cluster inference. Neuroimage 44:83–98PubMedCrossRef Smith SM, Nichols TE (2009) Threshold-free cluster enhancement: addressing problems of smoothing, threshold dependence and localisation in cluster inference. Neuroimage 44:83–98PubMedCrossRef
19.
Zurück zum Zitat Jellinger KA (2008) Different tau pathology pattern in two clinical phenotypes of progressive supranuclear palsy. Neurodegener Dis 5:339–346PubMedCrossRef Jellinger KA (2008) Different tau pathology pattern in two clinical phenotypes of progressive supranuclear palsy. Neurodegener Dis 5:339–346PubMedCrossRef
20.
Zurück zum Zitat Morris HR, Gibb G, Katzenschlager R, Wood N, Hanger DP, Strand C, Lashley T, Daniel SE, Lees AJ, Anderton BH, Revesz T (2002) Pathological, clinical and genetic heterogeneity in progressive supranuclear palsy. Brain 125:969–975PubMedCrossRef Morris HR, Gibb G, Katzenschlager R, Wood N, Hanger DP, Strand C, Lashley T, Daniel SE, Lees AJ, Anderton BH, Revesz T (2002) Pathological, clinical and genetic heterogeneity in progressive supranuclear palsy. Brain 125:969–975PubMedCrossRef
21.
Zurück zum Zitat Williams DR, de Silva R, Paviour DC, Pittman A, Watt HC, Kilford L, Holton JL, Revesz T, Lees AJ (2005) Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson’s syndrome and PSP—parkinsonism. Brain 128:1247–1258PubMedCrossRef Williams DR, de Silva R, Paviour DC, Pittman A, Watt HC, Kilford L, Holton JL, Revesz T, Lees AJ (2005) Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson’s syndrome and PSP—parkinsonism. Brain 128:1247–1258PubMedCrossRef
22.
Zurück zum Zitat Litvan I, Agid Y, Calne D, Campbell G, Dubois B, Duvoisin RC, Goetz CG, Golbe LI, Grafman J, Growdon JH, Hallett M, Jankovic J, Quinn NP, Tolosa E, Zee DS (1996) Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele–Richardson–Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology 47(1):1–9PubMedCrossRef Litvan I, Agid Y, Calne D, Campbell G, Dubois B, Duvoisin RC, Goetz CG, Golbe LI, Grafman J, Growdon JH, Hallett M, Jankovic J, Quinn NP, Tolosa E, Zee DS (1996) Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele–Richardson–Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology 47(1):1–9PubMedCrossRef
23.
Zurück zum Zitat Golbe LI, Ohman-Strickland PA (2007) A clinical rating scale for progressive supranuclear palsy. Brain 130:1552–1565PubMedCrossRef Golbe LI, Ohman-Strickland PA (2007) A clinical rating scale for progressive supranuclear palsy. Brain 130:1552–1565PubMedCrossRef
24.
Zurück zum Zitat Hoehn MM, Yahr MD (1967) Parkinsonism: onset, progression and mortality. Neurology 17(5):427–442PubMedCrossRef Hoehn MM, Yahr MD (1967) Parkinsonism: onset, progression and mortality. Neurology 17(5):427–442PubMedCrossRef
25.
Zurück zum Zitat Folstein MF, Folstein SE, McHugh PR (1975) “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12(3):189–198PubMedCrossRef Folstein MF, Folstein SE, McHugh PR (1975) “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12(3):189–198PubMedCrossRef
26.
Zurück zum Zitat Fahn S, Elton RL (1987) UPDRS Development Committee. Unified Parkinson’s Disease Rating Scale. In: Fahn S, Marsden CD, Calne DB, Goldstein M (eds) Recent developments in Parkinson’s disease. Macmillan, Florham Park, pp 153–163 Fahn S, Elton RL (1987) UPDRS Development Committee. Unified Parkinson’s Disease Rating Scale. In: Fahn S, Marsden CD, Calne DB, Goldstein M (eds) Recent developments in Parkinson’s disease. Macmillan, Florham Park, pp 153–163
27.
Zurück zum Zitat Lancaster JL, Woldorff MG, Parsons LM, Liotti M, Freitas CS, Rainey L, Kochunov PV, Nickerson D, Mikiten SA, Fox PT (2000) Automated Talairach atlas labels for functional brain mapping. Hum Brain Mapp 10(3):120–131PubMedCrossRef Lancaster JL, Woldorff MG, Parsons LM, Liotti M, Freitas CS, Rainey L, Kochunov PV, Nickerson D, Mikiten SA, Fox PT (2000) Automated Talairach atlas labels for functional brain mapping. Hum Brain Mapp 10(3):120–131PubMedCrossRef
28.
Zurück zum Zitat Smith SM, Zhang Y, Jenkinson M, Chen J, Matthews PM, Federico A, De Stefano N (2002) Accurate, robust and automated longitudinal and cross-sectional brain change analysis. Neuroimage 17(1):479–489PubMedCrossRef Smith SM, Zhang Y, Jenkinson M, Chen J, Matthews PM, Federico A, De Stefano N (2002) Accurate, robust and automated longitudinal and cross-sectional brain change analysis. Neuroimage 17(1):479–489PubMedCrossRef
29.
Zurück zum Zitat Smith SM, Jenkinson M, Woolrich MW, Beckmann CF, Behrens TEJ, Johansen-Berg H, Bannister PR, De Luca M, Drobnjak I, Flitney DE, Niazy R, Saunders J, Vickers J, Zhang Y, De Stefano N, Brady JM, Matthews PM (2004) Advances in functional and structural MR image analysis and implementation as FSL. Neuroimage 23(S1):208–219CrossRef Smith SM, Jenkinson M, Woolrich MW, Beckmann CF, Behrens TEJ, Johansen-Berg H, Bannister PR, De Luca M, Drobnjak I, Flitney DE, Niazy R, Saunders J, Vickers J, Zhang Y, De Stefano N, Brady JM, Matthews PM (2004) Advances in functional and structural MR image analysis and implementation as FSL. Neuroimage 23(S1):208–219CrossRef
30.
Zurück zum Zitat Acosta-Cabronero J, Williams GB, Pengas G, Nestor PJ (2010) Absolute diffusivities define the landscape of WM degeneration in Alzheimer’s disease. Brain 133(Pt 2):529–539PubMedCrossRef Acosta-Cabronero J, Williams GB, Pengas G, Nestor PJ (2010) Absolute diffusivities define the landscape of WM degeneration in Alzheimer’s disease. Brain 133(Pt 2):529–539PubMedCrossRef
31.
Zurück zum Zitat Beaulieu C (2002) The basis of anisotropic water diffusion in the nervous system—a technical review. NMR Biomed 15(7–8):435–455PubMedCrossRef Beaulieu C (2002) The basis of anisotropic water diffusion in the nervous system—a technical review. NMR Biomed 15(7–8):435–455PubMedCrossRef
32.
Zurück zum Zitat Della Nave R, Ginestroni A, Diciotti S, Salvatore E, Soricelli A, Mascalchi M (2011) AD is increased in the degenerating superior cerebellar peduncles of Friedreich’s ataxia. Neuroradiology 53(5):367–372PubMedCrossRef Della Nave R, Ginestroni A, Diciotti S, Salvatore E, Soricelli A, Mascalchi M (2011) AD is increased in the degenerating superior cerebellar peduncles of Friedreich’s ataxia. Neuroradiology 53(5):367–372PubMedCrossRef
33.
Zurück zum Zitat Weaver KE, Richards TL, Liang O, Laurino MY, Samii A, Aylward EH (2009) Longitudinal diffusion tensor imaging in Huntington’s disease. Exp Neurol 216(2):525–529PubMedCrossRef Weaver KE, Richards TL, Liang O, Laurino MY, Samii A, Aylward EH (2009) Longitudinal diffusion tensor imaging in Huntington’s disease. Exp Neurol 216(2):525–529PubMedCrossRef
34.
Zurück zum Zitat Williams DR, Holton JL, Strand C, Pittman A, de Silva R, Lees AJ, Revesz T (2007) Pathological tau burden and distribution distinguishes progressive supranuclear palsy—parkinsonism from Richardson’s syndrome. Brain 130:1566–1576PubMedCrossRef Williams DR, Holton JL, Strand C, Pittman A, de Silva R, Lees AJ, Revesz T (2007) Pathological tau burden and distribution distinguishes progressive supranuclear palsy—parkinsonism from Richardson’s syndrome. Brain 130:1566–1576PubMedCrossRef
35.
Zurück zum Zitat Litvan I, Hauw JJ, Bartko JJ, Lantos PL, Daniel SE, Horoupian DS (1996) Validity and reliability of the preliminary NINDS neuropathologic criteria for progressive supranuclear palsy and related disorders. J Neuropathol Exp Neurol 55:97–105PubMedCrossRef Litvan I, Hauw JJ, Bartko JJ, Lantos PL, Daniel SE, Horoupian DS (1996) Validity and reliability of the preliminary NINDS neuropathologic criteria for progressive supranuclear palsy and related disorders. J Neuropathol Exp Neurol 55:97–105PubMedCrossRef
36.
Zurück zum Zitat Dickson DW (1999) Neuropathologic differentiation of progressive supranuclear palsy and corticobasal degeneration. J Neurol 246(Suppl 2):II6–II15PubMedCrossRef Dickson DW (1999) Neuropathologic differentiation of progressive supranuclear palsy and corticobasal degeneration. J Neurol 246(Suppl 2):II6–II15PubMedCrossRef
37.
38.
Zurück zum Zitat Zhukareva V, Joyce S, Schuck T, Van Deerlin V, Hurtig H, Albin R, Gilman S, Chin S, Miller B, Trojanowski JQ, Lee VM (2006) Unexpected abundance of pathological tau in progressive supranuclear palsy WM. Ann Neurol 60(3):335–345PubMedCrossRef Zhukareva V, Joyce S, Schuck T, Van Deerlin V, Hurtig H, Albin R, Gilman S, Chin S, Miller B, Trojanowski JQ, Lee VM (2006) Unexpected abundance of pathological tau in progressive supranuclear palsy WM. Ann Neurol 60(3):335–345PubMedCrossRef
39.
Zurück zum Zitat Warmuth-Metz M, Naumann M, Csoti I, Solymosi L (2001) Measurement of the midbrain diameter on routine magnetic resonance imaging: a simple and accurate method of differentiating between Parkinson disease and progressive supranuclear palsy. Arch Neurol 58(7):1076–1079PubMedCrossRef Warmuth-Metz M, Naumann M, Csoti I, Solymosi L (2001) Measurement of the midbrain diameter on routine magnetic resonance imaging: a simple and accurate method of differentiating between Parkinson disease and progressive supranuclear palsy. Arch Neurol 58(7):1076–1079PubMedCrossRef
40.
Zurück zum Zitat Cosottini M, Ceravolo R, Faggioni L, Lazzarotti G, Michelassi MC, Bonuccelli U, Murri L, Bartolozzi C (2007) Assessment of midbrain atrophy in patients with progressive supranuclear palsy with routine magnetic resonance imaging. Acta Neurol Scand 116(1):37–42PubMedCrossRef Cosottini M, Ceravolo R, Faggioni L, Lazzarotti G, Michelassi MC, Bonuccelli U, Murri L, Bartolozzi C (2007) Assessment of midbrain atrophy in patients with progressive supranuclear palsy with routine magnetic resonance imaging. Acta Neurol Scand 116(1):37–42PubMedCrossRef
41.
Zurück zum Zitat Halliday GM, Macdonald V, Henderson JM (2005) A comparison of degeneration in motor thalamus and cortex between progressive supranuclear palsy and Parkinson’s disease. Brain 128:2272–2280PubMedCrossRef Halliday GM, Macdonald V, Henderson JM (2005) A comparison of degeneration in motor thalamus and cortex between progressive supranuclear palsy and Parkinson’s disease. Brain 128:2272–2280PubMedCrossRef
42.
Zurück zum Zitat Cordato NJ, Pantelis C, Halliday GM, Velakoulis D, Wood SJ, Stuart GW, Currie J, Soo M, Olivieri G, Broe GA, Morris JG (2002) Frontal atrophy correlates with behavioural changes in progressive supranuclear palsy. Brain 125(Pt 4):789–800PubMedCrossRef Cordato NJ, Pantelis C, Halliday GM, Velakoulis D, Wood SJ, Stuart GW, Currie J, Soo M, Olivieri G, Broe GA, Morris JG (2002) Frontal atrophy correlates with behavioural changes in progressive supranuclear palsy. Brain 125(Pt 4):789–800PubMedCrossRef
43.
Zurück zum Zitat Litvan I (2004) Update on progressive supranuclear palsy. Curr Neurol Neurosci Rep 4:296–302PubMedCrossRef Litvan I (2004) Update on progressive supranuclear palsy. Curr Neurol Neurosci Rep 4:296–302PubMedCrossRef
44.
Zurück zum Zitat Kier EL, Staib LH, Davis LM, Bronen RA (2004) MR imaging of the temporal stem: anatomic dissection tractography of the uncinate fasciculus, inferior occipitofrontal fasciculus, and Meyer’s loop of the optic radiation. AJNR Am J Neuroradiol 25(5):677–691PubMed Kier EL, Staib LH, Davis LM, Bronen RA (2004) MR imaging of the temporal stem: anatomic dissection tractography of the uncinate fasciculus, inferior occipitofrontal fasciculus, and Meyer’s loop of the optic radiation. AJNR Am J Neuroradiol 25(5):677–691PubMed
45.
Zurück zum Zitat Armstrong RA, Lantos PL, Cairns NJ (2009) Hippocampal pathology in progressive supranuclear palsy (PSP): a quantitative study of 8 cases. Clin Neuropathol 28(1):46–53PubMed Armstrong RA, Lantos PL, Cairns NJ (2009) Hippocampal pathology in progressive supranuclear palsy (PSP): a quantitative study of 8 cases. Clin Neuropathol 28(1):46–53PubMed
46.
47.
Zurück zum Zitat Henderson JM, Carpenter K, Cartwright H, Halliday GM (2000) Loss of thalamic intralaminar nulei in progressive supranuclear palsy and Parkinsons disease: clinical and therapeutic implications. Brain 123:1410–1421PubMedCrossRef Henderson JM, Carpenter K, Cartwright H, Halliday GM (2000) Loss of thalamic intralaminar nulei in progressive supranuclear palsy and Parkinsons disease: clinical and therapeutic implications. Brain 123:1410–1421PubMedCrossRef
48.
Zurück zum Zitat Rizzo G, Martinelli P, Manners D, Scaglione C, Tonon C, Cortelli P, Malucelli E, Capellari S, Testa C, Parchi P, Montagna P, Barbiroli B, Lodi R (2008) Diffusion-weighted brain imaging study of patients with clinical diagnosis of corticobasal degeneration, progressive supranuclear palsy and Parkinson’s disease. Brain 131:2690–2700PubMedCrossRef Rizzo G, Martinelli P, Manners D, Scaglione C, Tonon C, Cortelli P, Malucelli E, Capellari S, Testa C, Parchi P, Montagna P, Barbiroli B, Lodi R (2008) Diffusion-weighted brain imaging study of patients with clinical diagnosis of corticobasal degeneration, progressive supranuclear palsy and Parkinson’s disease. Brain 131:2690–2700PubMedCrossRef
49.
Zurück zum Zitat Schofield EC, Hodges JR, Macdonald V, Cordato NJ, Kril JJ, Halliday GM (2010) Cortical atrophy differentiates Richardson's syndrome from the parkinsonian form of progressive supranuclear palsy. Mov Disord. Dec 13. doi:10.1002/mds.23295 PubMedCrossRef Schofield EC, Hodges JR, Macdonald V, Cordato NJ, Kril JJ, Halliday GM (2010) Cortical atrophy differentiates Richardson's syndrome from the parkinsonian form of progressive supranuclear palsy. Mov Disord. Dec 13. doi:10.​1002/​mds.​23295 PubMedCrossRef
Metadaten
Titel
In vivo evaluation of white matter pathology in patients of progressive supranuclear palsy using TBSS
verfasst von
Jitender Saini
Bhavani Shankara Bagepally
Mangalore Sandhya
Shaik Afsar Pasha
Ravi Yadav
Pramod Kumar Pal
Publikationsdatum
01.07.2012
Verlag
Springer-Verlag
Erschienen in
Neuroradiology / Ausgabe 7/2012
Print ISSN: 0028-3940
Elektronische ISSN: 1432-1920
DOI
https://doi.org/10.1007/s00234-011-0983-7

Weitere Artikel der Ausgabe 7/2012

Neuroradiology 7/2012 Zur Ausgabe

Interventional Neuroradiology

Medial branch neurotomy in low back pain

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Schwindelursache: Massagepistole lässt Otholiten tanzen

14.05.2024 Benigner Lagerungsschwindel Nachrichten

Wenn jüngere Menschen über ständig rezidivierenden Lagerungsschwindel klagen, könnte eine Massagepistole der Auslöser sein. In JAMA Otolaryngology warnt ein Team vor der Anwendung hochpotenter Geräte im Bereich des Nackens.

Schützt Olivenöl vor dem Tod durch Demenz?

10.05.2024 Morbus Alzheimer Nachrichten

Konsumieren Menschen täglich 7 Gramm Olivenöl, ist ihr Risiko, an einer Demenz zu sterben, um mehr als ein Viertel reduziert – und dies weitgehend unabhängig von ihrer sonstigen Ernährung. Dafür sprechen Auswertungen zweier großer US-Studien.

Bluttest erkennt Parkinson schon zehn Jahre vor der Diagnose

10.05.2024 Parkinson-Krankheit Nachrichten

Ein Bluttest kann abnorm aggregiertes Alpha-Synuclein bei einigen Menschen schon zehn Jahre vor Beginn der motorischen Parkinsonsymptome nachweisen. Mit einem solchen Test lassen sich möglicherweise Prodromalstadien erfassen und die Betroffenen früher behandeln.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.